This is a promotional website intended for UK healthcare professionals. If you are a member of the public, please click here.
Welcome to the Radioligand Therapy Hub.
Please confirm whether you are a UK healthcare professional or a member of the public. This website is not suitable for healthcare professionals outside of the United Kingdom.
Current Evidence for PRRT
In this 30-minute masterclass, Dr Navalkissoor shares his knowledge of the evidence supporting the use of 177Lu-oxodotreotide, the first approved PRRT for NETs, and the factors influencing patient selection for PRRT.
Patient selection and challenges in PRRT
Dr Shaunak Navalkissoor speaks about patient selection for peptide receptor radionuclide therapy (PRRT), with a focus on molecular imaging, and describes the challenges associated with this process.
When to refer patients to PRRT centre
Dr Mohid Khan describes the service model of NET care, information required for referral, patient preparation and selection, and more.
PRRT Masterclass Videos 2020
Browse our catalogue of videos and watch experts in the field of NETs discuss their clinical insights on the evidence for the diagnosis, management and treatment of NETs, with a focus on PRRT.
PRRT Masterclass videos
Browse our catalogue of videos and watch experts in the field of NETs discuss their clinical insights on the evidence for the diagnosis, management and treatment of NETs, with a focus on PRRT.
Identifying progression in NETs: clinical, biochemical and imaging markers
Prof. Martyn Caplin reports on emerging methods for neuroendocrine tumour (NET) diagnosis, including the NETest and sheds light on available treatment options for...